Sepsis-induced myocardial dysfunction

Shock

Volumn 28, Issue 3, 2007, Pages 265-269

  Sharma, Avadhesh C ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Apoptosis; Caspase 3; Cecal inoculum model; Endothelin converting enzyme; Polymicrobial sepsis; Rat ventricular myocytes

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 8; CYTOCHROME C; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 2; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; RECEPTOR; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOSOL; DIASTOLE; ENZYME PHOSPHORYLATION; HEART DISEASE; HEART LEFT VENTRICLE RELAXATION; HEART MITOCHONDRION; HUMAN; LABORATORY TEST; MEDIATOR RELEASE; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; ENDOTHELIN-1; HEART; HEART FAILURE, CONGESTIVE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 34548050165     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000235090.30550.fb     Document Type: Review

References (61)

1. Bone RC: Sir Isaac Newton, sepsis, SIRS, CARS. Crit Care Med 24:1125-1128, 1996.
2. Glauser MP, Zannetti G, Baumgartner JD, Cohen J: Septic shock pathogenesis. Lancet 338:732-736, 1991.
3. Wenzel RP, Edmond MB: Managing antibiotic resistance. N Engl J Med 343:1961-1963, 2001.
4. Kochanek KD, Smith BL: Deaths: preliminary data for 2002. Natl Vital Stat Rep 52:1-48, 2004.
5. Court O, Kumar A, Parrillo JE, Kumar A: Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6:500-508, 2002.
6. Gupta A, Brahmbhatt S, Kapoor R, Loken L, Sharma AC: Chronic peritoneal sepsis: myocardial dysfunction, endothelin and signaling mechanism. Front Biosci 10:3183-3205, 2005.
7. Levy RJ, Piel DA, Acton PD, Zhou R, Ferrari VA, Karp JS, Deutschman CS: Evidence of myocardial hibernation in the septic heart. Crit Care Med 33:2752-2756, 2005.
8. Levy RJ, Deutschman CS: Evaluating myocardial depression in sepsis. Shock 22:1-10, 2004.
9. Meldrum DR, Wan M, Tsai BM, Kher A, Pitcher JM, Brown JW, Meldrum KK: Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury. Front Biosci 10:1835-1867, 2005.
10. Conlon BA, Ross JD, Law WR: Advances in understanding adenosine as a plurisystem modulator in sepsis and the systemic inflammatory response syndrome (SIRS). Front Biosci 10:2548-2565, 2005.
11. Ren J, Wu S: A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction? Front Biosci 11:15-22, 2006.
12. McDonough KH, Virag JI: Sepsis-induced myocardial dysfunction and myocardial protection from ischemia/reperfusion injury. Front Biosci 11:23-32, 2006.
13. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928-1948, 2004.
14. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29:1469-1477, 1997.
15. Ren J, Ren BH, Sharma AC: Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock 18:285-288, 2002.
16. Lefer AM, Martin J: Origin of myocardial depressant factor in shock. Am J Physiol 218:1423-1427, 1970.
17. Parker JL, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984.
18. Brahmbhatt S, Gupta A, Sharma AC: Bigendothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation. Mol Cell Biochem 271:225-237, 2005.
19. Sam AD II, Sharma AC, Law WR, Ferguson JL: Splanchnic vascular control during sepsis and endotoxemia. Front Biosci 2:e72-e92, 1997.
20. Gupta A, Aberle N, Ren J, Sharma AC: Endothelin-converting enzyme-1-mediated signaling in adult rat ventricular myocyte contractile function and apoptosis during polymicrobial sepsis. J Mol Cell Cardiol 38:527-537, 2005.
21. Omachi A, Sharma AC, Alden KJ, Sam AD, Ferguson JL: Induction of peritoneal sepsis increases the susceptibility of isolated hearts to a calcium paradox-mediated injury. Shock 17:193-198, 2002.
22. Chopra M, Sharma AC: Prolonged duration of sepsis causes elevated endothelin-1 and myocardial dysfunction correlating with DNA fragmentation [abstract]. 25(Suppl 1):P23, 2006.
23. Tschaikowsky K, Sanger S, Lehnert N, Kaul M, Ritter J: Endothelin in septic patients: effect on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28:1854-1860, 2000.
24. Riedemann NC, Guo R, Ward PA: Novel strategies for treatment of sepsis. Nat Med 9:517-524, 2003.
25. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayishi Y, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent, vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
26. Sugden PH: An overview of endothelin signaling in cardiac myocytes. J Mol Cell Cardiol 35:871-886, 2003.
27. Kimura S, Kasuya Y, Sawamura T, Shinimi O, Sugita Y, Yanagisawa M, Goto K, Masaki T: Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 13:S5-S7, 1989.
28. Emoto N, Yanagisawa M: Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268, 1995.
29. Schmidt M, Kroger B, Jacob E, Seulberger H, Subkowski T, Otter R, Meyer T, Schmalzing G, Hillen H: Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 356:238-243, 1994.
30. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485, 1994.
31. Ergul A, Walker CA, Goldberg A, Baicu SC, Hendrick JW, King MK, Spinale FG: ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol Heart Circ Physiol 278:H2050-H2056, 2000.
32. Kobayashi T, Miyauochi T, Sakai S, Yamaguchi I, Goto K, Sugishita Y: Endothelin converting enzyme (ECE) and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction. J Cardiovasc Pharmacol 31:S417-S420, 1998.
33. Kelly RA, Eid H, Kramer BK, O'Neill M, Liang BT, Reers M, Smith TW: Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by pertussis toxin sensitive pathway. J Clin Invest 86:1164-1171, 1990.
34. Kramer BK, Smith TW, Kelly RA: Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of protein kinase C dependent Na+ H+ exchanger. Circ Res 68:269-279, 1991.
35. Suzuki T, Kumazaki T, Mitsui Y: Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191:823-830, 1993.
36. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP: Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526-538, 1993.
37. Xuan Y-T, Wang O-L, Whorton AR: Regulation of endothelin-induced Ca2+ mobilization in smooth muscle cells by protein kinase C. Am J Physiol 266:C1560-C1567, 1994.
38. Cheng CM, Hong HJ, Liu JC, Shih NL, Juan SH, Loh SH, Chan P, Chen JJ, Cheng TH: Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol Pharmacol 63:1002-1011, 2003.
39. Kobayashi T, Miyauchi T, Sakai S, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Expression of endothelin-1, ETA and ETB receptors and ECE and distribution of endothelin-1 in failing rat heart. Am J Physiol 276:H1197-H1206, 1999.
40. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr: Endothelin in human congestive heart failure. Circulation 89:1580-1586, 1994.
41. Giannessi D, Delry S, Vitale RL: The role of endothelins and their receptors in heart failure. Pharm Res 43:111-126, 2001.
42. Gupta A, Sharma AC: Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases. Mol Cell Biochem 265:47-65, 2004.
43. Gupta A, Sharma AC: Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia. Shock 20:375-381, 2003.
44. Gupta A, Aberle N, Kapoor R, Ren J, Sharma AC: BigET-1 induced contractile function is mediated via p38-MAPK phosphorylation in adult rat ventricular myocytes during sepsis. Biochim Biophys Acta 1741:127-139, 2005.
45. Clerk A, Michael A, Sugden PH: Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G-protein coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol 142:523-535, 1998.
46. Cattaruzza M, Dimigen C, Ehrenreich H, Hecker M: Stretch-induced endothelin B receptor mediated apoptosis in vascular smooth muscle cells. FASEB J 14:991-998, 2000.
47. Kapoor RL, Gupta A, Sharma AC: Endothelin-1 (ET-1) precursor, bigET-1 via p38-MAPK affects nitric oxide production in adult rat ventricular myocytes (ARVM) following sepsis (Abstract). FASEB J 18:A590, 2004.
48. Power C, Fanning N, Redmond PH: Cellular apoptosis and organ injury in sepsis. Shock 18:197-211, 2002.
49. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 96:2247-2259, 1995.
50. Bratton SB, MacFarlane M, Cain K, Cohen GM: Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 256:27-33, 2000.
51. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995.
52. Livingstone C, Patel G, Jones N: ATF-2 contains a phosphorylation- dependent transcriptional activation domain. EMBO J 14:1785-1797, 1995.
53. Gonzalez A, Fortuno MA, Querejeta R, Ravassa S, Lopez B, Lopez N, Diez J: Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59:549-562, 2003.
54. Matsuzawa A, Ichijo H: Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J Biochem (Tokyo) 130:1-8, 2001.
55. Chien K: Stress pathways in heart failure. Cell 98:555-558, 1999.
56. Clerk A, Sugden PH: Stress-responsive mitogen activated protein kinases (c-jun N-terminal kinases and p38 mitogen activated protein kinases) in the myocardium. Circ Res 83:345-352, 1998.
57. Molnar A, Theodoras AM, Zon LI, Kyriakis JM: Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J Biol Chem 272:13229-13235, 1997.
58. Liu Q, Hofmann PA: Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 286:2204-2212, 2004.
59. Watts JA, Kline JA, Thornton LR, Grattan RM, Brar SS: Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J Mol Cell Cardiol 36:141-150, 2004.
60. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW, Armstrong RC, Kitsis RN: Inhibition of cardiac myocytes apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of G alpha (q) transgenic mice. Circulation 108:3036-3041, 2003.
61. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 163:218-225, 2001.